Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Top Cited Papers
Open Access
- 8 March 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 33 (10), 1190-1200
- https://doi.org/10.1093/eurheartj/ehr453
Abstract
Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population worldwide and may confer increased cardiometabolic risk with consequent adverse cardiovascular outcomes independent of traditional cardiovascular risk factors and the metabolic syndrome. It is characterized almost universally by insulin resistance and is strongly associated with type 2 diabetes and obesity. Non-alcoholic fatty liver disease is a marker of pathological ectopic fat accumulation combined with a low-grade chronic inflammatory state. This results in several deleterious pathophysiological processes including abnormal glucose, fatty acid and lipoprotein metabolism, increased oxidative stress, deranged adipokine profile, hypercoaguability, endothelial dysfunction, and accelerated progression of atherosclerosis. This ultimately leads to a dysfunctional cardiometabolic phenotype with cardiovascular mortality representing the main mode of premature death in NAFLD. This review is aimed at introducing NAFLD to the clinical cardiologist by discussing in-depth the evidence to date linking NAFLD with cardiovascular disease, reviewing the likely mechanisms underlying this association, as well as summarizing from a cardiologist's perspective, current and potential future treatment options for this increasingly prevalent disease.Keywords
This publication has 100 references indexed in Scilit:
- A position statement on NAFLD/NASH based on the EASL 2009 special conferenceJournal of Hepatology, 2010
- Cardiovascular effects of marine omega-3 fatty acidsThe Lancet, 2010
- Increased Whole‐Body Adiposity Without a Concomitant Increase in Liver Fat is Not Associated With Augmented Metabolic DysfunctionObesity, 2010
- Pericardial Fat Volume Correlates With Inflammatory Markers: The Framingham Heart StudyObesity, 2010
- Pericardial Fat Burden on ECG-Gated Noncontrast CT in Asymptomatic Patients Who Subsequently Experience Adverse Cardiovascular EventsJACC: Cardiovascular Imaging, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusThe New England Journal of Medicine, 2010
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implicationsHepatology, 2009
- Adipokines, Insulin Resistance, and Coronary Artery CalcificationJournal of the American College of Cardiology, 2008
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseHepatology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005